JointHealth™ express   November 18, 2010

Special BC Edition: Making Sense of New Treatment Options for Autoimmune Diseases

The use of biologic response modifiers or "biologics" (medicines created by biological processes, as opposed to chemically) has improved patient care, profoundly.

Ensuring that British Columbians who most need treatment with biologic medications have provincial reimbursement access is a priority for patient groups like Arthritis Consumer Experts (ACE). But more recently, another issue has emerged that directly affects the principle of patient choice in this area - Subsequent Entry Biologics (SEBs).

In this special BC issue of JointHealth™ monthly, Arthritis Consumer Experts wants to help British Columbian patients to understand the complexities behind the development, regulation, and BC PharmaCare listings of SEBs.

The topics covered in this issue are: We welcome your questions or comments, please email us at